Demographics, stage, and baseline hematologic parameters
| Demographics | |
| Male:female | 45:15 |
| Age: | 53.5 (30-73) y |
| Performance status | 0 (0-2) |
| Ann Arbor stage for patients with NHL | |
| Stage IV | 37 |
| Stage III | 6 |
| Rai stage and baseline hematologic parameters for patients with CLL | |
| Stage | |
| IV | 3 |
| III | 3 |
| II | 6 |
| I | 5 |
| Median WBC | 63.3/mm3 (11.7-353.0) |
| Median HGB | 13 g/dL (11.1-15.3) |
| Median HCT | 36.6% (20-44.9) |
| Median PLTS | 139,000/mm3 (81-281) |
| Demographics | |
| Male:female | 45:15 |
| Age: | 53.5 (30-73) y |
| Performance status | 0 (0-2) |
| Ann Arbor stage for patients with NHL | |
| Stage IV | 37 |
| Stage III | 6 |
| Rai stage and baseline hematologic parameters for patients with CLL | |
| Stage | |
| IV | 3 |
| III | 3 |
| II | 6 |
| I | 5 |
| Median WBC | 63.3/mm3 (11.7-353.0) |
| Median HGB | 13 g/dL (11.1-15.3) |
| Median HCT | 36.6% (20-44.9) |
| Median PLTS | 139,000/mm3 (81-281) |
NHL, non-Hodgkin lymphoma; CLL, chronic lymphocytic leukemia; WBC, white blood cell count; HGB, hemoglobin; HCT, hematocrit; PLTS, platelets.